Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model

26 Jan 2011

Abstract excerpt

African horse sickness (AHS) is a lethal viral disease of equids, which is transmitted by Culicoides midges that become infected after biting a viraemic host. The use of live attenuated vaccines has been vital for the control of this disease in endemic regions. However, there are safety concerns over their use in non-endemic countries. Research efforts over the last two decades have therefore focused on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Vector-Borne Animal Diseases
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21298069
DOI: 10.1371/journal.pone.0016503

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse ModelPMID 21298069Read ↗

African Horse Sickness: A Review of Current Understanding and Vaccine DevelopmentSemantic proximity Read ↗

Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)Semantic proximity Read ↗

Understanding the basis for African horse sickness virus pathogenicity using a murine infection modelSemantic proximity Read ↗

Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All SerotypesSemantic proximity Read ↗

VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.Semantic proximity Read ↗

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challengeSemantic proximity Read ↗

Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virusSemantic proximity Read ↗

Development of a live attenuated vaccine candidate for equid alphaherpesvirus 1 control: a step towards efficient protection.Semantic proximity Read ↗

BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal ChallengeSemantic proximity Read ↗

Mouse Models of Mayaro VirusSemantic proximity Read ↗

Side-by-side evaluation of two mouse models for Crimean-Congo Hemorrhagic Fever Virus infectionSemantic proximity Read ↗

American mink as an animal model to study SARS-CoV-2 and vaccine responseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.